The first randomised trial to investigate the use of trastuzumab emtansine (T-DM1) – an antibody-guided drug – for the initial treatment of HER2- (human epidermal growth factor receptor-2) positive metastatic breast cancer has shown that it makes a significant difference to the time women live without their disease worsening. Dr Sara Hurvitz, one of the [...]
Breast cancer patients who have a strong social support system in the first year after diagnosis are less likely to die or have a recurrence of cancer, according to new research from Vanderbilt-Ingram Cancer Center (VICC) and the Shanghai Institute of Preventive Medicine. The study, led by first author Meira Epplein, Ph.D., assistant professor of [...]
Researchers say they’ve developed a method that reasonably predicts which men undergoing prostate cancer treatment will suffer from impotence as a result. The strategy could someday be one more ingredient in the decision-making process for men faced with the choice of whether to undergo certain prostate cancer therapies or simply “wait and see” if the [...]